Ellipses Pharma Ltd | Reg: 09542015 | Created: 2015-04-14 | Status: active | Type: ltd Ellipsés Pharma is a specialized, privately held company dedicated to the research, development, and commercialization of innovative oncology therapies. Established in London, UK, Ellipsès operates as an independent entity focused on addressing critical unmet needs within the cancer treatment landscape. The company’s core business centers around identifying novel therapeutic targets and developing advanced drug candidates targeting a range of cancers including breast, lung, and melanoma. Ellipsés Pharma employs a team of highly skilled scientists, clinicians, and regulatory experts with significant experience in pharmaceutical development, clinical trials, and market access strategy. Currently, Ellipsès Pharma’s activities encompass early-stage research, preclinical studies, formulation development, and strategic partnerships aimed at bringing new therapies to patients. The company's international presence is currently limited to collaborations within Europe and North America. Ellipsés Pharma operates under the SIC codes - 74909: Other professional, scientific and technical activities n.e.c. As a Skilled Worker visa holder with an A rating, Ellipsès Pharma actively seeks strategic alliances for expanding its capabilities and accelerating drug development timelines.

Ellipses Pharma Ltd | Reg: 09542015 | Created: 2015-04-14 | Status: active | Type: ltd Ellipsés Pharma is a specialized, privately held company dedicated to the research, development, and commercialization of innovative oncology therapies. Established in London, UK, Ellipsès operates as an independent entity focused on addressing critical unmet needs within the cancer treatment landscape. The company’s core business centers around identifying novel therapeutic targets and developing advanced drug candidates targeting a range of cancers including breast, lung, and melanoma. Ellipsés Pharma employs a team of highly skilled scientists, clinicians, and regulatory experts with significant experience in pharmaceutical development, clinical trials, and market access strategy. Currently, Ellipsès Pharma’s activities encompass early-stage research, preclinical studies, formulation development, and strategic partnerships aimed at bringing new therapies to patients. The company's international presence is currently limited to collaborations within Europe and North America. Ellipsés Pharma operates under the SIC codes - 74909: Other professional, scientific and technical activities n.e.c. As a Skilled Worker visa holder with an A rating, Ellipsès Pharma actively seeks strategic alliances for expanding its capabilities and accelerating drug development timelines.